Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Vertex Pharmaceuticals 3.334, Baxter International 2.96.
Vertex Pharmaceuticals vs Baxter International Net Worth and Market Cap
Vertex Pharmaceuticals (VRTX) and Baxter International (BAX) are peers in Healthcare. Vertex Pharmaceuticals reported revenue of $3.3B as of Q2 2026, compared with $3.0B for Baxter International. Vertex Pharmaceuticals leads on revenue.
Vertex Pharmaceuticals's gross margin is 85.3% versus 34.9% for Baxter International. Vertex Pharmaceuticals's net margin is 33.0% versus 4.3% for Baxter International.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Vertex Pharmaceuticals, Baxter International.| Metric | Vertex Pharmaceuticals | Baxter International |
|---|---|---|
| Market Cap | - | - |
| Revenue | $3.33B | $2.96B |
| Cost of Revenue | $489.00M | $1.93B |
| Gross Profit | $2.85B | $1.03B |
| Operating Income | $1.25B | $217.00M |
| Net Income | $1.10B | $126.00M |
| R&D Expense | $994.00M | $129.00M |
| Earnings Per Share | $4.31 | $0.24 |
| Gross Margin | 85.3% | 34.9% |
| Operating Margin | 37.4% | 7.3% |
| Net Profit Margin | 33.0% | 4.3% |
| Free Cash Flow | $1.01B | $32.00M |
| Cumulative Free Cash Flow | $17.24B | $35.82B |
| Operating Cash Flow | $1.13B | $285.00M |
| Cash & Equivalents | $6.14B | $2.15B |